Found 31 matching trials
Efficacy Study of DeepDDH System in Screening Infants with Developmental Dysplasia of the Hip (DDH)
NATo ascertain the efficacy of the DeepDDH system, a deep learning framework,...
Location
Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine
Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD
NABioCogBankAD aims at building a prospective clinical practice cohort of 244...
Researching the Effect of Aerobic Exercise on Cancer
NAThis study is being done to answer the following question: Will aerobic exe...
Status
Active Not Recruiting
Location
University of California, Los Angeles (Data or Specimen Analysis Only)
Application of n-3 Fatty to Patient of Jaundice
N/AThe safety and efficacy of ω-3 fatty acid in patients with obstructive jaun...
Location
Hepatic Surgery Center of Tongji Hospital
Healthcare Integrity & Anti-Fraud Enforcement
N/AThe PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed ...
Status
Enrolling By Invitation
Location
Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
PHASE1A first-in-class adoptive immunotherapy we called ThINKK, for Therapeutic I...
Location
The Hospital for Sick Children
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)
PHASE1This is a single center phase 1 trail to observe safety and efficacy of met...
Location
Department of Oncology, Ruijin Hospital
Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat
PHASE1This is a multi-center, phase 1b study of AMG 655 in combination with borte...
Location
Multiple Locations
Study of Afuresertib Combined With Paclitaxel in Gastric Cancer
PHASE1This is a Phase Ib, open-label, dose-escalation study to determine the Maxi...
Location
Novartis Investigative Site
Study With SCB-313 (Recombinant Human TRAIL-Trimer Fusion Protein) for Treatment of Malignant Pleural Effusions
PHASE1The purpose of this study is to evaluate the safety, tolerability, prelimin...
Location
Liverpool Hospital